Edoxaban Tosylate

Author：

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.11, Iss.2, 2011-04, pp. : 129-135

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Edoxaban: A New Oral Direct Factor Xa Inhibitor

By Camm A. John

Drugs, Vol. 71, Iss. 12, 2011-08 ,pp. : 1503-1526

Adis International

Access to resources Recommend Favorite

Bioavailability and Safety of the Factor Xa Inhibitor Edoxaban and the Effects of Quinidine in Healthy Subjects

Clinical Pharmacology In Drug Development, Vol. 2, Iss. 4, 2013-10 ,pp. : 358-366

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of spin trapping and P2Y receptor antagonism in the neuroprotective effects of 2,2'-pyridylisatogen tosylate and related compounds

By Menton K. Spedding M. Gressens P. Villa P. Williamson T. Markham A.

European Journal of Pharmacology, Vol. 444, Iss. 1, 2002-05 ,pp. : 53-60

Elsevier

Access to resources Recommend Favorite